Medication adherence in children and adolescents with HIV infection: Associations with behavioral impairment

AIDS Patient Care and STDs

Volumn 25, Issue 3, 2011, Pages 191-200

  Malee, Kathleen ^a   Williams, Paige ^b   Montepiedra, Grace ^b   McCabe, Marie ^c   Nichols, Sharon ^d   Sirois, Patricia A ^e   Storm, Deborah ^f   Farley, John ^g   Kammerer, Betsy ^h  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^c KENNEDY KRIEGER INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f The State University of New Jersey   (United States)

^g UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^h BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

AGED; ARTICLE; BEHAVIOR DISORDER; CAREGIVER; CHILD; CHILD HEALTH; CONDUCT DISORDER; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERACTIVITY; IMPULSIVENESS; LEARNING DISORDER; LIFE STRESS; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRESCRIPTION; PSYCHOSOMATIC DISORDER; SCHOOL CHILD; SELF REPORT; SOCIAL PSYCHOLOGY; TREATMENT REFUSAL;

ADOLESCENT; ADOLESCENT BEHAVIOR; ANTI-HIV AGENTS; CHILD; CHILD BEHAVIOR DISORDERS; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; MALE; PATIENT COMPLIANCE;

EID: 79952504869     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2010.0181     Document Type: Article

References (41)

1. Brady MT, Oleske JM, Williams, PL et al. Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era. J Acquir Immune Defic Syndr 2010;53:86-94.
2. Patel K, Hernan MA, Williams PL, et al. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: A 10-year follow-up study. Clin Infect Dis 2008;46:507-515. (Pubitemid 351263487)
3. Byrne M, Honig J, Jurgrau A, Heffernan S, Donahue M. Achieving adherence with antiretroviral medications for pediatric HIV disease. AIDS Read 2002;12:151-164. (Pubitemid 34496640)
4. Pontali E. Facilitating adherence to highly active antiretroviral therapy in children with HIV infection: What are the issues and what can be done? Paediatr Drugs 2005;7:137-149. (Pubitemid 41019940)
5. Brown LK, Lourie KJ, Pao M. Children and adolescents living with HIV and AIDS: A review. J Child Psychol Psychiatry 2000;41:81-96. (Pubitemid 30113620)
6. Steele RG, Nelson TD, Cole BP. Psychosocial functioning in children with AIDS and HIV infection: Review of the literature from a socioecological framework. J Dev Behav Pediatr 2007;28:58-69. (Pubitemid 46423279)
7. Hammani N, Nostlinger C, Hoeree T, Lefevre P, Jonckheer T, Kolsteren P. Integrating adherence to highly active antiretroviral therapy into children's daily lives: A qualitative study. Pediatrics 2004;114:591-597.
8. Martin S, Elliot-DeSorbo DK, Wolters PL, et al. Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents. Pediatr Infect Dis J 2007;26:61-67. (Pubitemid 46045754)
9. Mellins C, Brackis-Cott E, Dolezal C, Abrams E. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virusinfected children. Pediatr Infect Dis J 2004;23:1035-1041. (Pubitemid 40824294)
10. Naar-King S, Arfken C, Frey M, Harris M, Secord E, Ellis D. Psychosocial factors and treatment adherence in paediatric HIV/AIDS. AIDS Care 2006;18:621-628. (Pubitemid 44050520)
11. Malee K, Williams PL, Montepiedra G, et al. The role of cognitive functioning in medication adherence of children and adolescents with HIV infection. J Pediatr Psychol 2009;34:164-175.
12. Simoni JM, Montgomery A, Martin E, New M, Demas PA, Rana S. Adherence to antiretroviral therapy for pediatric HIV infection: A qualitative systematic review with recommendations for research and clinical management. Pediatrics 2007;119: e1371-e1384.
13. Williams P, Storm D, Montepiedra G, et al. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection. Pediatrics 2006;118: e1745-e1757. (Pubitemid 46397550)
14. Haberer J, Mellins C. Pediatric adherence to HIV antiretroviral therapy. Curr HIV/AIDS Rep 2009;6:194-200.
15. Merzel C, VanDevanter N, Irvine M. Adherence to antiretroviral therapy among older children and adolescents with HIV: A qualitative study of psychosocial contexts. AIDS Patient Care STDs 2008;22:977-987.
16. Michaud PA, Suris JC, Thomas R, Gnehm HE, Cheseaux JJ; The Swiss HIV Mother & Child Cohort Study. Coping with HIV infection. Swiss Med Wkly 2010;140:247-253.
17. Havens JF, Mellins CA. Psychiatric aspects of HIV/AIDS. In: Rutter M, Bishop D, Pine D, Scott S, Stevenson JS, Taylor EA, Thapar A, eds. Rutter's Child and Adolescent Psychiatry, 5th ed. Oxford: Blackwell Publishing, 2008:945-955.
18. Nozyce M, Lee S, Wiznia A, et al. A behavioral and cognitive profile of clinically stable HIV infected children. Pediatrics 2006;117:763-770. (Pubitemid 46063218)
19. Mellins CA, Smith R, O'Driscoll P, et al. High rates of behavioral problems in perinatally HIV-infected children are not linked to HIV disease. Pediatrics 2003;111:384-393. (Pubitemid 36177160)
20. Gadow KG, Chernoff M, Williams PL, et al. Co-occurring psychiatric symptoms in children perinatally infected with HIV and peer comparison sample. J Dev Behav Pediatr 2010;31:116-128.
21. Mellins CA, Brackis-Cott E, Leu C, et al. Rates and types of psychiatric disorders in perinatally human immunodeficiency virus-infected youth and seroreverters. J Child Psychol Psychiatry 2009;50:1131-1138.
22. Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol 2000;19:124-133.
23. Murphy DA, Belzer M, Durako S, Sarr M, Wilson C, Muenz L. Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus. Arch Pediatr Adolesc Med 2005;159:764-770. (Pubitemid 41126841)
24. Walkup J, Akincigil A, Bilder, S, Rosato NS, Crystal S. Psychiatric diagnosis and antiretroviral adherence among adolescent Medicaid beneficiaries diagnosed with human immunodeficiency virus/acquired immunodeficiency syndrome. J Nerv Ment Dis 2009;197:354-361.
25. Rapoff MA. Adherence to Pediatric Medical Regimens. New York: Kluwer Academic/Plenum, 1999.
26. Gortmaker SL, Hughes M, Cervia J, et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med 2001;345:1522-1528. (Pubitemid 33144917)
27. Van Dyke RB, Lee S, Johnson GM, et al. Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have Human Immunodeficiency Virus Infection. Pediatrics 2002;109: e61.
28. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30. (Pubitemid 30432540)
29. Bangberg DR. Preventing HIV antiretroviral resistance through better monitoring of treatment adherence. J Infect Dis 2008;197: S272-278.
30. Conners CK. Conners Rating Scales: Technical Manual, Revised. North Tonawanda, NY: MultiHealth Systems, 1989.
31. Center for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994;43:1-10.
32. Gortmaker SL, Lenderking WR, Clark C, Lee S, Fowler MG, Oleske J. Development and use of a pediatric quality of life questionnaire in AIDS clinical trials: Reliability and validity of the General Health Assessment for Children (GHAC). In: Drotar D, ed. Assessing Pediatric Health-Related Quality of Life and Functional Status: Implications for Research, Practice and Policy. Mahwah, NJ: Lawrence Feldbaum Associates, 1998:219-235.
33. Lee GM, Gortmaker SL, McIntosh K, Hughes MD, Oleske JM. Quality of life for children and adolescents: Impact of HIV infection and antiretroviral treatment. Pediatrics 2006;117:273-283. (Pubitemid 46071588)
34. Wallander JL, Varni JW. Effects of pediatric chronic physical disorders on child and family adjustment. J Child Psychol Psychiatry 1998;39:29-46. (Pubitemid 28059668)
35. Van Rie A, Harrington PR, Dow A, Robertson K. Neurologic and neurodevelopmental manifestations of pediatric HIV/AIDS: A global perspective. Eur J Paediatr Neurol 2007;11:1-9. (Pubitemid 46076105)
36. Valcour VG, Shiramizu BT, Shikuma CM. HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications. J Leukoc Biol 2010;87:1-6.
37. Tashiro C. The meaning of race in healthcare and researchpart 2. Current controversies and emerging research. Pediatr Nurs 2005;31:305-308.
38. Wadsworth ME, Raviv T, Reinhard C, Wolff B, Santiago CD, Einhorn L. Association between poverty and child functioning: The role of children's poverty-related stress. J Loss Trauma 2008;13:156-185.
39. Kishiyama MM, Boyce WT, Jimenez AM, Perry LM, Knight RT. Socioeconomic disparities affect prefrontal function in children. J Cogn Neurosci 2008;21:1106-1115.
40. Silver E, Heneghan A, Bauman L, Stein R. The relationship of depressive symptoms to parenting competence and social support in inner-city mothers of young children. Matern Child Health J 2006;10:105-112.
41. Rutter M. Environmentally mediated risks for psychopathology: Research strategies and findings. J Am Acad Child Adolesc Psychiatry 2005;44:18.